Authors: MCLEAN S GANONG A SEYMOUR PA BRYCE DK CRAWFORD RT MORRONE J REYNOLDS LS SCHMIDT AW ZORN S WATSON J FOSSA A DEPASQUALE M ROSEN T NAGAHISA A TSUCHIYA M HEYM J

Citation: S. Mclean et al., CHARACTERIZATION OF CP-122,721 - A NONPEPTIDE ANTAGONIST OF THE NEUROKININ NK1 RECEPTOR, The Journal of pharmacology and experimental therapeutics, 277(2), 1996, pp. 900-908

Authors: LOWE JA DROZDA SE MCLEAN S BRYCE DK CRAWFORD RT ZORN S MORRONE J APPLETON TA LOMBARDO F

Citation: Ja. Lowe et al., A WATER-SOLUBLE BENZAZEPINE CHOLECYSTOKININ-B RECEPTOR ANTAGONIST, Bioorganic & medicinal chemistry letters, 5(17), 1995, pp. 1933-1936

Authors: LOWE JA HAGEMAN DL DROZDA SE MCLEAN S BRYCE DK CRAWFORD RT ZORN S MORRONE J BORDNER J

Citation: Ja. Lowe et al., 5-PHENYL-3-UREIDOBENZAZEPIN-2-ONES AS CHOLECYSTOKININ-B RECEPTOR ANTAGONISTS, Journal of medicinal chemistry, 37(22), 1994, pp. 3789-3811

Authors: DOUGHERTY PM PALECEK J ZORN S WILLIS WD

Citation: Pm. Dougherty et al., COMBINED APPLICATION OF EXCITATORY AMINO-ACIDS AND SUBSTANCE-P PRODUCES LONG-LASTING CHANGES IN RESPONSES OF PRIMATE SPINOTHALAMIC TRACT NEURONS, Brain research reviews, 18(2), 1993, pp. 227-246

Authors: LEVINSON AI YI Z WHEATLEY L KOZLOWSKI L ZORN S

Citation: Ai. Levinson et al., IGM RHEUMATOID-FACTOR PRODUCED IN RESPONSE TO STAPHYLOCOCCUS-AUREUS COWAN .1. ROLE OF PROTEIN A AND PREFERENTIAL UTILIZATION OF VH3 HEAVY-CHAINS, The Journal of immunology, 150(8), 1993, pp. 237-237